Liminatus Pharma, Inc.
LIMN
$5.54
-$0.61-9.92%
NASDAQ
| 12/31/2024 | 03/31/2024 | ||||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -87.10% | -99.48% | |||
| Total Receivables | 288.25% | -- | |||
| Inventory | -- | -- | |||
| Prepaid Expenses | 609.09% | -- | |||
| Finance Division Loans and Leases Current | -- | -- | |||
| Total Finance Division Other Current Assets | -- | -- | |||
| Other Current Assets | 66.79% | -- | |||
| Total Current Assets | 135.70% | -- | |||
|
|
|||||
| Total Current Assets | 135.70% | -- | |||
| Net Property, Plant & Equipment | 0.00% | -- | |||
| Long-term Investments | -- | -- | |||
| Goodwill | -- | -- | |||
| Total Other Intangibles | -- | -- | |||
| Finance Div Loans & Leases LT | -- | -- | |||
| Total Finance Div Other LT Assets | -- | -- | |||
| Total Other Assets | -- | -- | |||
| Total Assets | 141.26% | -- | |||
|
|
|||||
| Total Accounts Payable | 59.06% | -- | |||
| Total Accrued Expenses | 260.96% | -- | |||
| Short-term Debt | 24.44% | -- | |||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | |||
| Finance Division Debt Current | -- | -- | |||
| Total Finance Division Other Current Liabilities | 0.00% | -- | |||
| Total Other Current Liabilities | 0.00% | -- | |||
| Total Current Liabilities | 37.22% | -- | |||
|
|
|||||
| Total Current Liabilities | 37.22% | -- | |||
| Long-Term Debt | -- | -- | |||
| Short-term Debt | 24.44% | -- | |||
| Capital Leases | -- | -- | |||
| Finance Division Debt Non Current | -- | -- | |||
| Total Finance Division Other Non Current Liabilities | -- | -- | |||
| Total Other Liabilities | -- | -- | |||
| Total Liabilities | 37.22% | -- | |||
|
|
|||||
| Common Stock & APIC | 0.00% | -- | |||
| Retained Earnings | -14.12% | -- | |||
| Treasury Stock & Other | -- | -- | |||
| Total Common Equity | -22.45% | -62.33% | |||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | |||
| Preferred Stock Non Redeemable | -- | -- | |||
| Preferred Stock Convertible | -- | -- | |||
| Preferred Stock, Others | -- | -- | |||
| Total Preferred Equity | -- | -- | |||
|
|
|||||
| Total Common Equity | -22.45% | -62.33% | |||
| Total Preferred Equity | -- | -- | |||
| Total Minority Interest | -- | -- | |||
| Total Equity | -22.45% | -62.33% | |||
|
|
|||||